Critics say the drug manufacturer only provided, at best, modest evidence the drug worked and then only in limited trials.
The problem, critics say, is that the drug’s manufacturer, Janssen, provided the FDA at best modest evidence it worked and then only in limited trials. It presented no information about the safety of Spravato for long-term use beyond 60 weeks. And three patients who received the drug died by suicide during clinical trials, compared with none in the control group, raising red flags Janssen and the FDA dismissed.
Dr. Jess Fiedorowicz, director of the Mood Disorders Center at the University of Iowa and a member of the FDA advisory committee that reviewed the drug, described its benefit as “almost certainly exaggerated” after hearing the evidence. The expert panel cleared the drug according to the evidence that the agency and Janssen had determined was sufficient. Dr. Matthew Rudorfer, an associate director at the National Institute of Mental Health, concluded that the “benefits outweighed the risks.” Explaining his “yes” vote, he said: “I think we’re all agreeing on the very important, and sometimes life-or-death, risk of inadequately treated depression that factored into my equation.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Soundcheck: The 13 Best Music Releases Of The WeekIt's been recalled by the FDA
Consulte Mais informação »
Jojo Siwa's Claire's Makeup Recalled Over AsbestosThe FDA has deemed it 'dangerous.'
Consulte Mais informação »
FDA unveils new guidelines for e-cigarette makersThe U.S. Food and Drug Administration on Tuesday carved out new recommendations ...
Consulte Mais informação »
Kroger berry recall: Hepatitis A prompts frozen berries FDA warning
Consulte Mais informação »
JoJo Siwa's Makeup Kit At Claire's Was Recalled For Having AsbestosThe FDA has sent out an official warning against this makeup kit, making it the second advisory against the retailer this year.
Consulte Mais informação »